ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,630Medicare Part D Prescriptions Filled, Including Refills

Rank: 94 out of 3734

$729K Total Retail Price of All Prescriptions

Rank: 285 out of 3734

756 Patients Receiving at Least One Drug in Part D
46%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 756 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

7% of this provider’s 756 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 9,192 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LISINOPRIL 1,009 516 1 3
OMEPRAZOLE 981 552 2 4
METFORMIN HCL 889 482 3 8
SIMVASTATIN 806 460 4 1
METOPROLOL TARTRATE 569 310 5 6
AMLODIPINE BESYLATE 534 321 6 5
PRAVASTATIN SODIUM 532 289 7 15
LEVOTHYROXINE SODIUM 488 253 8 2
HYDROCHLOROTHIAZIDE 450 232 9 9
TRAMADOL HCL 396 161 10 20
FUROSEMIDE 314 194 11 7
GABAPENTIN 304 115 12 17
FLUTICASONE PROPIONATE 294 105 13 46
GLIMEPIRIDE 273 160 14 37
CYCLOBENZAPRINE HCL 256 60 R 15 87
RANITIDINE HCL 239 106 16 32
ADVAIR DISKUS 234 100 17 35
PROAIR HFA 229 98 18 83
CITALOPRAM HBR 217 99 19 16
VENTOLIN HFA 216 74 20 70
MELOXICAM 206 114 21 52
ATENOLOL 196 116 22 13
ALENDRONATE SODIUM 182 155 23 26
FLOVENT HFA 167 59 24 199
CLOPIDOGREL 165 105 25 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 158 83 26 27
INSULIN SYRINGE 150 106 27 109
TAMSULOSIN HCL 145 92 28 29
SPIRIVA 141 94 29 40
TRAZODONE HCL 137 57 30 49
PLAVIX 136 90 31 39
JANUVIA 131 93 32 50
GLIPIZIDE 130 80 33 57
WARFARIN SODIUM 128 82 34 10
NAPROXEN 126 63 35 101
DIOVAN 125 87 36 31
FENOFIBRATE 121 29 37 81
DONEPEZIL HCL 111 94 38 25
CARVEDILOL 110 70 39 30
LOVASTATIN 106 29 40 41
LANTUS 104 53 41 54
LOSARTAN POTASSIUM 102 71 42 21
IBUPROFEN 98 30 43 75
ENALAPRIL MALEATE 95 58 44 63
ATORVASTATIN CALCIUM 90 48 45 11
SINGULAIR 87 42 46 95
OXYBUTYNIN CHLORIDE 86 32 47 151
AMLODIPINE BESYLATE-BENAZEPRIL 85 43 48 56
PHENYTOIN SODIUM EXTENDED 85 28 48 149
ZOLPIDEM TARTRATE 80 46 50 24
DOXAZOSIN MESYLATE 78 60 51 100
GLYBURIDE 76 55 R 52 64
DICLOFENAC SODIUM 75 26 53 127
HYDROCODONE-ACETAMINOPHEN 73 53 S3 54 12
OXYCODONE-ACETAMINOPHEN 73 29 S2 54 51
PREDNISONE 72 34 56 42
GLIPIZIDE ER 70 36 57 119
FAMOTIDINE 68 42 58 60
ACETAMINOPHEN-CODEINE 67 40 S3 59 123
SERTRALINE HCL 65 31 60 18
TERAZOSIN HCL 63 37 61 136
LEVEMIR 60 39 62 202
MOMETASONE FUROATE 59 29 63 275
HUMALOG MIX 75-25 59 41 63 253
VERAPAMIL ER 59 27 63 96
MECLIZINE HCL 59 34 63 139
METOPROLOL SUCCINATE 59 44 63 14
HYDRALAZINE HCL 58 54 68 111
CARISOPRODOL 54 22 R 69 134
NOVOLIN 70-30 53 32 70 252
HYDROXYZINE HCL 51 23 R 71 208
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 16, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.